Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

  • March 2025 quarter CPI above expectations – but RBA cut still likely
    March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    • News

  • Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    • News

  • Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    • News

  • Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    • News

  • Spenda Secures $3M Term Loan to Accelerate Growth
    Spenda Secures $3M Term Loan to Accelerate Growth
    • News

As competitors withdraw, Coventry carries on with 10.8% earnings growth

  • In News
  • October 13, 2023
  • Alinda Gupta
As competitors withdraw, Coventry carries on with 10.8% earnings growth

The Australian government has pledged about $100 billion to infrastructure over the next decade. There is a massive spotlight on high-growth industries like infrastructure, mining and construction, especially as immigration booms and property prices rise. For companies like industrial products distributor Coventry Group (ASX: CYG), this is the opportunity to milk the potential cash cow.

In just the first three months of FY24, Coventry’s sales reached $94.6 million, up over 6.1% on Q1 FY23. Its unaudited EBITDA of $5.4 million was up 10.8%.

Group CEO and Managing Director of Coventry Group, Robert Bulluss, said, “The Group delivered solid FY24 quarter one sales and unaudited EBITDA growth. Initiatives to grow EBITDA % and Sales to 10% in the medium term have delivered early positive improvements, and our strategy based on specialisation and service excellence is continuing to be resilient. These buy-side and sell-side initiatives were implemented early in the financial year and started to become evident in the month of September with EBITDA up 26.7% on the pcp. We expect the run-rate from these initiatives to continue to improve over the December quarter.”

Coventry supplies a range of customisable products and tools for industrial use. These include fastening, cabinet hardware, hydraulics, lubrications, fire suppression, and refuelling systems. Its primary end markets are mining and resources, infrastructure, commercial construction and industrial avenues. 

With an expansive geographical base across Australia and New Zealand, Coventry functions through its two distinct business arms: Fluid Systems (supplying hydraulics, lubrications and such) and Trade Distribution (comprising Konnect and Artia and Nubco divisions for fastening systems, hardware and the like).

Due to New Zealand’s recessionary environment, the Company saw some weakness in the Konnect and Artia New Zealand business and the businesses’ exposure to residential construction through roofing screws. Konnect is among the top industrial fasteners business in New Zealand. 

What’s more, as competitors slowly withdraw from the market due to increasing inflationary pressures, Coventry expects to become stronger and more prominent. There are already signs of green shoots in the economy driven by record rates of immigration.

In FY23, Coventry’s sales revenue was up 11.2% on FY22 to $358.5 million, while Underlying EBITDA improved 9.7% to $17 million. The Company ended FY23 with $3.8 million cash in hand. It also upgraded its enterprise resource planning (ERP) solution for $5.5 million, incorporating the Microsoft suite. 

Coventry holds a modest market share in a multi-billion-dollar fragmented market. The Company has some plans to expand its presence, including new branch openings, branch refurbishments, business development, product range expansion and an enhanced focus on sales and marketing. 

Plus, its board and management aim to leverage the scale benefits of the platform established over recent years. Specifically, its goal is to achieve best-in-class trade distribution margins over time. 

Despite the overall optimism, the Company acknowledged the ongoing market uncertainty, with demand still suspended in limbo, resulting in Coventry’s inability to provide an FY24 guidance. However, the first quarter seems to paint a positive picture. 

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx cyg
  • construction
  • coventry group
  • industrial products
  • konnect
  • robert bulluss
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.